ECS panels have proven to identify patient carrier status as accurately as traditional single gene tests. Disease selection for panel inclusion has been addressed by both Counsyl publications and professional society statements. Professional societies, such as the Association of Molecular Pathologists (AMP) and the American College of Medical Genetics (ACMG) have also issued standards and guidelines for variant interpretation. As the leader in the field, Counsyl is committed to achieving high clinical specificity and sensitivity through thoughtful panel design, custom assays and rigorous variant curation.
Genetics in Medicine 2017; doi:10.1038/gim.2017.69 Beauchamp KA, Muzzey D, Wong KK, et al.
PLoS One. 2014;9(12):e114391. PMID 25494330 Lazarin GA, Hawthorne F, Collins NS, et al.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Genet Med. May 2015;17(5):405-424. PMID 25741868 Richards S, Aziz N, Bale S, et al.
Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population.
Genetic Testing and Molecular Biomarkers. 2016;20(9):504-509. doi:10.1089/gtmb.2015.0302 Mehta N, Lazarin G, Spiegel E et al.
Obstet Gynecol 2017;129:e35–40 2 American College of Obstetricians and Gynecologists.
Expanded carrier screening in reproductive medicine—points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine.
Obstet Gynecol2015;125:653–662 Edwards JG, Feldman G, Goldberg J et al.
Eur J Hum Genet. Jun 2016;24(6):e1-e12. PMID 26980105 Henneman L, Borry P, Chokoshvili D, et al.
Genetics in Medicine. 2016;18(12):1214-1217. doi:10.1038/gim.2016.30. Arjunan A, Litwack K, Collins N, Charrow J.